Cooper Companies Inc (NYSE:COO) Director Gary S. Petersmeyer sold 799 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $286.88, for a total value of $229,217.12. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Shares of COO opened at $294.81 on Friday. Cooper Companies Inc has a 52 week low of $216.47 and a 52 week high of $299.00. The firm has a market capitalization of $14.42 billion, a PE ratio of 25.64, a PEG ratio of 2.27 and a beta of 0.88. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.27 and a quick ratio of 0.75.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.38. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. As a group, analysts expect that Cooper Companies Inc will post 12.01 EPS for the current year.

Several research firms have weighed in on COO. Raymond James upped their target price on Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 6th. BMO Capital Markets upped their target price on Cooper Companies from $306.00 to $320.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 6th. Piper Jaffray Companies restated an “overweight” rating and set a $325.00 target price on shares of Cooper Companies in a research note on Wednesday, March 6th. KeyCorp upped their target price on Cooper Companies from $296.00 to $314.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. Finally, Stephens upped their target price on Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $307.90.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. increased its holdings in Cooper Companies by 46.3% in the third quarter. Russell Investments Group Ltd. now owns 26,652 shares of the medical device company’s stock valued at $7,376,000 after purchasing an additional 8,432 shares during the period. Engineers Gate Manager LP acquired a new stake in Cooper Companies in the third quarter valued at $208,000. Private Advisor Group LLC acquired a new stake in Cooper Companies in the third quarter valued at $307,000. HL Financial Services LLC acquired a new stake in Cooper Companies in the third quarter valued at $427,000. Finally, Janney Montgomery Scott LLC increased its holdings in Cooper Companies by 9.0% in the third quarter. Janney Montgomery Scott LLC now owns 15,207 shares of the medical device company’s stock valued at $4,215,000 after purchasing an additional 1,253 shares during the period. Institutional investors own 99.95% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Cooper Companies Inc (COO) Director Sells $229,217.12 in Stock” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://theolympiareport.com/2019/03/15/insider-selling-cooper-companies-inc-coo-director-sells-229217-12-in-stock.html.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Return on Equity (ROE)

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.